Oppenheimer Asset Management Inc. lessened its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 20.2% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 111,938 shares of the pharmacy operator’s stock after selling 28,362 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Walgreens Boots Alliance were worth $8,645,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Franklin Resources Inc. raised its holdings in Walgreens Boots Alliance by 24.7% in the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock valued at $1,448,939,000 after buying an additional 3,662,302 shares during the period. Arrowstreet Capital Limited Partnership raised its holdings in Walgreens Boots Alliance by 471.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock valued at $258,077,000 after buying an additional 2,718,800 shares during the period. Vanguard Group Inc. raised its holdings in Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after buying an additional 1,926,108 shares during the period. Glenview Capital Management LLC purchased a new stake in Walgreens Boots Alliance in the 2nd quarter valued at about $136,875,000. Finally, Harding Loevner LP raised its holdings in Walgreens Boots Alliance by 85.3% in the 3rd quarter. Harding Loevner LP now owns 2,844,207 shares of the pharmacy operator’s stock valued at $115,725,000 after buying an additional 1,309,179 shares during the period. Institutional investors and hedge funds own 61.18% of the company’s stock.

In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director John Anthony Lederer acquired 20,000 shares of the stock in a transaction dated Thursday, October 26th. The shares were bought at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the transaction, the director now owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The disclosure for this purchase can be found here. Insiders own 14.80% of the company’s stock.

Several analysts recently issued reports on WBA shares. Deutsche Bank started coverage on shares of Walgreens Boots Alliance in a report on Monday, December 4th. They issued a “hold” rating and a $78.00 price objective on the stock. Raymond James Financial restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. Leerink Swann lowered shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 1st. Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a report on Thursday, October 26th. Finally, SunTrust Banks set a $72.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a report on Sunday, October 15th. Nine equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Buy” and a consensus price target of $86.15.

Walgreens Boots Alliance Inc (WBA) opened at $74.08 on Thursday. The firm has a market capitalization of $73,370.00, a PE ratio of 20.46, a price-to-earnings-growth ratio of 1.29 and a beta of 1.22. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. Walgreens Boots Alliance Inc has a 52-week low of $63.82 and a 52-week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. Walgreens Boots Alliance’s revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.10 EPS. equities research analysts anticipate that Walgreens Boots Alliance Inc will post 5.59 earnings per share for the current year.

Walgreens Boots Alliance declared that its Board of Directors has approved a share buyback program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s board believes its stock is undervalued.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.16%. The ex-dividend date was Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is presently 44.20%.

TRADEMARK VIOLATION NOTICE: “Oppenheimer Asset Management Inc. Has $8.65 Million Stake in Walgreens Boots Alliance Inc (WBA)” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of international trademark & copyright law. The correct version of this news story can be read at https://www.watchlistnews.com/oppenheimer-asset-management-inc-has-8-65-million-stake-in-walgreens-boots-alliance-inc-wba/1802532.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.